The effects of portal shunts on intestinal cytochrome P450 3A activity - Reply

被引：4

作者：

Chalasani, N ^{[1
]}

Gorski, JC

Patel, NH

Hall, SD

Galinsky, RE

机构：

[1] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA

[2] Indiana Univ, Sch Med, Dept Radiol, Indianapolis, IN USA

[3] Purdue Univ, Sch Pharm, W Lafayette, IN 47907 USA

来源：

HEPATOLOGY | 2002年 / 35卷 / 06期

关键词：

D O I：

10.1053/jhep.2002.33827

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1550 / 1551

页数：2

共 7 条

[1] Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: Effects of transjugular intrahepatic portosystemic shunts [J].

Chalasani, N ;

Gorski, JC ;

Patel, NH ;

Hall, SD ;

Galinsky, RE .

HEPATOLOGY, 2001, 34 (06) :1103-1108

[2] The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin [J].

Gorski, JC ;

Jones, DR ;

Haehner-Daniels, BD ;

Hamman, MA ;

O'Mara, EM ;

Hall, SD .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (02) :133-143

[3] Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt [J].

Huonker, M ;

Schumacher, YO ;

Ochs, A ;

Sorichter, S ;

Keul, J ;

Rössle, M .

GUT, 1999, 44 (05) :743-748

[4] Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression [J].

Lown, KS ;

Bailey, DG ;

Fontana, RJ ;

Janardan, SK ;

Adair, CH ;

Fortlage, LA ;

Brown, MB ;

Guo, WS ;

Watkins, PB .

JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (10) :2545-2553

[5] CONCEPTS BASIC TO PHARMACOKINETICS [J].

TOZER, TN .

PHARMACOLOGY & THERAPEUTICS, 1981, 12 (01) :109-131

[6] Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics [J].

Wacher, VJ ;

Silverman, JA ;

Zhang, YC ;

Benet, LZ .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (11) :1322-1330

[7]

YANG JS, 2001, BR J CLIN PHARM, V52, pP472

← 1 →